Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

NARecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

October 15, 2025

Conditions
TramadolNalbuphineAbdominal SurgeriesPediatric Cancer
Interventions
DRUG

Nalbuphine

this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)

DRUG

Tramadol

this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).

Trial Locations (1)

11769

RECRUITING

National cancer institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER